Schoenherr, working with Latham & Watkins and Orrick Herrington & Sutcliffe, and has advised French diagnostic center group Cerba HealthCare on the acquisition of the Lifebrain Group from Investindustrial. Chiomenti and Wolf Theiss advised Investindustrial on the deal.
According to Schoenherr, Lifebrain owns and operates diagnostic laboratory centers throughout Italy and in Austria. Closing is subject to regulatory clearances and is expected by the end of 2021.
Cerba HealthCare, majority-owned by EQT Partners, is headquartered in France and operates a network of clinical analysis and diagnostic centers in Europe. It also operates globally with its business unit for clinical studies to validate new active components and vaccines.
Schoenherr’s team included Partners Christian Herbst, Maximilian Lang, Volker Weiss, and Andreas Natterer, Counsels Teresa Waidmann, Veronika Wolfbauer, and Johannes Stalzer, Attorneys Alfred Amann, Evelin Hlina, and Iliyana Sirakova, and Associates Nina Zafoschnig, Michael Kern, Daniel Neuwirth-Riedl, and Daniel Komarek.
Wolf Theiss' team included Partners Roland Marko, Ralf Peschek, Kurt Retter, Dieter Spranz, Manfred Essletzbichler, Clara Gordon, and Georg Kresbach, Counsels Wolfgang Lauchner and Jochen Anweiler, Senior Associate Harald Strahberger, Consultant Carolin Ziegler, and Associates Peter Pichlmayr, Dorothea Rauchegger, Manuela Regner, Theresia Welser, Phillip Wrabetz, Dominik Engel, Dominik Koenig, and Paul Berger.